-
Alemtuzumab Induction Is Safe, and Permits the Avoidance of Steroids in the Majority of Renal Transplant Recipients.
-
Alemtuzumab Use in a Single Center Pediatric Heart Transplant Cohort.
-
Allograft Crescent Predicts Graft Failure in Recurrent IgA Nephropathy Patients.
-
Allograft Cytokine Activation and Elevated Tissue Indoleamine 2,3-Dioxygenase Gene and Protein Expression in Rejecting Pig Transplants.
-
Alloimmune Quiescence in Recipients with Long-Term Surviving Kidney Grafts.
-
Alternations in Amplitude of Low Frequency Fluctuation in Renal Allograft Recipients That Received Tacrolimus or Sirolimus: An fMRI Study.
-
Ambiguous Nucleic Acid Tests (NAT) Results – Case of a Donor with Intermittent HCV NAT(+) but No HCV Transmission.
-
Ambulatory Antibiotic Utilization and Outcomes in an Adult Kidney Transplant Population: A Pharmacovigilance Analysis.
-
Ambulatory Blood Pressure Monitoring Detects High Prevalence of Hypertension in Recipients of Non-Renal Transplants.
-
An Analysis of Tacrolimus XL Dosing in Obese Kidney Transplant Recipients.
- « Previous Page
- 1
- …
- 11
- 12
- 13
- 14
- 15
- …
- 181
- Next Page »